Introducing the GenapSys Sequencer
Sequencing without compromise

GS111 Sequencer

The GenapSys™ Sequencer is exceptionally accurate, incredibly scalable, and amazingly affordable.


Innovative electrical detection enables accurate, scalable and affordable sequencing.

GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.


GenapSys technology achieves
>80% of bases >Q30

The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.


The latest GenapSys news & upcoming events.

Press Release: GenapSys Raises $90M Series C Led by Foresite Capital to Commercialize Its Breakthrough Electronic Gene Sequencer

Redwood City, CA (Nov. 20, 2019) -- GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed.
Read more >

GenomeWeb: GenapSys Targeting Smaller Labs With New Low-Cost Sequencer

GenapSys Targeting Smaller Labs With New Low-Cost Sequencer
Read more >

ABRF 2020 Annual Meeting

Meet GenapSys at the Association of Biomolecular Resource Facilities
Read more >

Get in touch with GenapSys.

Receive the latest news or request a quote.